Navigation Links
Center for the Study of Traumatic Encephalopathy announces new findings
Date:1/27/2009

former NFL player to be examined neuropathologically and not have CTE. Chris Nowinski, co-founder of the non-profit Sports Legacy Institute (SLI), explained, "This means that six of six deceased former NFL players between the ages of 25 and 50 have had severe brain damage that, if they had lived, would have developed into debilitating dementia."

According to Ann McKee, MD, CSTE co-director and a leading neuropathologist who specializes in degenerative brain diseases, "CTE has been described for approximately 80 years. Initially referred to as dementia pugilistica because of the boxers that were originally studied, CTE is now being seen in other athletes. Although the neuropathological findings of CTE are, in some ways, similar to those we see in Alzheimer's disease, they represent a distinct disease with a distinct cause, namely repetitive head trauma." McKee conducted the neuropathological analysis on the brains of both Grimsley and McHale. Her findings of significant CTE in their brains were independently confirmed by E. Tessa Hedley-Whyte, MD, professor of pathology at Harvard Medical School and a neuropathologist at Massachusetts General Hospital.

Due to the growing strength of these findings linking brain trauma on the football field to CTE, a number of living former NFL players have recently agreed to join three-time Super Bowl champion Ted Johnson and seven other former NFL players to donate their brains to Boston University School of Medicine upon death. The new donors include three members of the NFL's 88 Plan, joining Ralph Wenzel, another 88 Plan donor.

The 88 Plan was named after former NFL star John Mackey's jersey number. Mackey, a Hall of Fame tight end for the Colts in the 1960s and 70s, suffers from severe dementia. The plan was created by the NFL to provide families of former players who suffer from some form of dementia with money to support their care. Members of the Plan, by definition, have been diagnosed
'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. NCQA Awards Accredited Status to ValueOptions(R) North Carolina Employer Solutions Service Center
2. Centene Foundation for Quality Healthcare Awards Grant to Center for Black Womens Wellness
3. Global Med Technologies(R) Licenses Multi-System Solution to One of Top Ten U.S. Donor Centers
4. Come On In, Says One of the Pros! The Neigel Center for Cosmetic & Laser Surgery Hosts Their First Annual Pre Super Bowl Open House!
5. Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia
6. National Center for Sports Safety Responds to Indictment of Kentucky Coach
7. U.S. Preventive Medicine Recommends Changing CDC Name to Centers for Disease Prevention and Control
8. Center for Healthcare Research & Transformation Releases Cover Michigan - a Report on Healthcare Coverage and Access
9. Research identifies risk factors that affected World Trade Center evacuation
10. Providence Service Corporation Provides The Center on Budget and Policy Priorities Preliminary Analysis of Potential Medicaid Assistance for States in the House Economic Recovery Package
11. VisionQwest Resource Group, Inc. Opens Nursing and English Review Centers in Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... 29, 2015 , ... Healthpointe, one of Southern California’s leading ... MD., PhD into their world-class multidisciplinary team of physicians and specialists. Dr. ... Irwindale and La Tijera-Los Angeles. , Orthopedic surgeons of Healthpointe, such as ...
(Date:6/29/2015)... ... 2015 , ... Mediaplanet has released the first edition of ... 12-page, glossy, full-color special section hit newsstands Friday, June 26th, and was distributed ... copies, with an estimated readership of 1.3 million. The digital component is being ...
(Date:6/29/2015)... NEW YORK, NEW YORK (PRWEB) , ... June ... ... obstructive sleep apnea (OSA) is now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. ... and Drug Administration and is an alternative to continuous positive airway pressure (CPAP), ...
(Date:6/29/2015)... ... 2015 , ... National HealthCare Associates recently released a list ... 40-center nursing home group. Sixteen of their centers were rated “Best in Class” ... one or more customer service areas. Those centers received the prestigious “Customer Experience ...
(Date:6/29/2015)... ... 2015 , ... With Urgent Care Medicine now serving a vital role in ... Urgent Care Medicine and the Medical Society of Delaware to provide its latest professional ... health care professionals. , According to Matthew Bader, Exam Master CEO and President, “This ...
Breaking Medicine News(10 mins):Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3
... , HARBIN, China, Sept. 9 ... CKGT), a vertically integrated grower,developer, manufacturer and marketer of ... the Rodman and Renshaw Annual Global Investment,Conference to be ... Kangtai,Cactus Biotech will present as part of the Asia ...
... , , Obesity Experts ... , SILVER SPRING, Md., Sept. 9 ... to Overcome and Prevent (STOP) Obesity Alliance, and two former US Surgeons ... act on the inclusion of obesity as the largest and most urgent ...
... , CAMBRIDGE, Mass., Sept. 9 ... enterprise content compliance software solutions for ... Software-as-a-Service (SaaS) solution for managing clinical trial disclosure requirements. The ... a robust offering that automates compliance with global regulatory mandates ...
... , , TARRYTOWN, N.Y., Sept. 9 Bayer ... (R) 2 blood glucose meters -- Pink and Purple. , ... same unique easy to use(1) features as the original silver BREEZE2 ... the meter itself, so users do not have to handle individual ...
... They can get variety of illnesses from the sexually transmitted ... A U.S. health advisory committee on Wednesday will discuss whether ... transmitted human papillomavirus (HPV), for use in boys as well ... has asked the U.S. Food and Drug Administration to approve ...
... , , TITUSVILLE, ... to impact up to 20 percent of children(1) and 4 percent ... underdiagnosed: researchers estimate up to 20 percent of U.S. school-aged children ... but only 7.8 percent report receiving an ADHD diagnosis.(3) Meanwhile, it ...
Cached Medicine News:Health News:China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009 2Health News:China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009 3Health News:Obesity Driving America's Healthcare to a Tipping Point 2Health News:Obesity Driving America's Healthcare to a Tipping Point 3Health News:Obesity Driving America's Healthcare to a Tipping Point 4Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 2Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 3Health News:Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences Companies 4Health News:Bayer's BREEZE(R)2 Meter Available in Two New Vibrant Colors for a Limited Time 2Health News:FDA Panel Weighs Approving HPV Vaccine for Males 2Health News:FDA Panel Weighs Approving HPV Vaccine for Males 3Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 2Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 3Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 4Health News:CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 5
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: